Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 1316096, 12 pages
https://doi.org/10.1155/2018/1316096
Review Article

Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis

1Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
2Beijing Hospital of Traditional Chinese Medicine, Clinical Medical College of Traditional Chinese Medicine, Capital Medical University, Beijing, China
3Department of Hematology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

Correspondence should be addressed to Xinyi Chen; moc.621@9270iynixnehc

Received 4 June 2018; Accepted 22 October 2018; Published 12 December 2018

Academic Editor: Carlo Visco

Copyright © 2018 Jia Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jia Wang, Ya Li, Chong Wang, et al., “Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis,” BioMed Research International, vol. 2018, Article ID 1316096, 12 pages, 2018. https://doi.org/10.1155/2018/1316096.